Lilly Research Laboratories, et al.; Withdrawal of Approval of 57 Abbreviated Antibiotic Drug Applications

الملخص

The Food and Drug Administration (FDA) is withdrawing approval of 57 abbreviated antibiotic drug applications (AADA's). The holders of the AADA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.